Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Reexamination Certificate
2002-03-14
2008-11-04
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
C424S169100, C530S388400, C800S006000
Reexamination Certificate
active
07445782
ABSTRACT:
The present invention relates to antibodies immunologically specific for an attaching and effacingEscherichia coli(AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
REFERENCES:
patent: 5585098 (1996-12-01), Coleman
patent: 5932250 (1999-08-01), Stolle et al.
patent: 5972721 (1999-10-01), Bruno et al.
patent: 6162441 (2000-12-01), Chae et al.
patent: 6204004 (2001-03-01), Kaper et al.
patent: 6942861 (2005-09-01), McKee et al.
patent: 2002/0012658 (2002-01-01), Williams et al.
patent: 2003/0185856 (2003-10-01), Lee et al.
patent: 2004/0258664 (2004-12-01), Pitcovski et al.
patent: 2005/0226861 (2005-10-01), Nash et al.
patent: 2006/0223986 (2006-10-01), Chiou
patent: 2078716 (1992-09-01), None
patent: 0873755 (1998-10-01), None
patent: 0873755 (1999-10-01), None
patent: 10-298105 (1998-11-01), None
patent: 97/40063 (1997-10-01), None
patent: WO 9740063 (1997-10-01), None
patent: 98/14209 (1998-04-01), None
patent: 99/24576 (1999-05-01), None
patent: 9924576 (1999-05-01), None
patent: WO 9924576 (1999-05-01), None
patent: WO 9941614 (1999-08-01), None
patent: WO 0052055 (2000-09-01), None
patent: 02/053179 (2002-07-01), None
Anicetti, Vincent R et al, Immunization Procedures ofE.coliproteins, Appl. Biochemistry and Biotechnology, vol. 22, pp. 151-168, 1989.
An, Hongyan et al, Distribution of a novel locus call paa (porcine attaching and effacing associated) among entericEscherichia coli, Mechansims in the pathogenesis of Enteric Diseases 2, 2000, p. 179-184.
Akita, EM et al, J. Immnological Methods, vol. 160, pp. 207-214, 1993, Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenicE.colistrain.
Heller, ED, Research in Veterinary Science, vol. 18, pp. 117-120, 1975, The immune response of hens to multipleEscherichia coliinjections and transfer of immunoglobulin to the egg and hatched chick.
Li, Yuling et al, Infection and Immunity, Sep. 2000, pp. 5090-5095, Human response toEscherichia coliO157:H7 infection: antibodies to secreted virulence factors.
Malkinson, M, Immunology, 1965, vol. 9, pp. 311-317, The transmission of passive immunity toEscherichia colifrom mother to young in the Domestic fowl (Gallus domesticus).
Ryu, H et al, Infection and immunity, vol. 69(2), pp. 640-649, Feb. 2001.
Schmidt, P et al, J. Vet. Med. vol. B36, pp. 619-628, 1989, Chicken egg antibodies for Prophylaxis and Therapy of infectious intestinal diseases.
Batisson et al (Aug. 2003) Infection and Immunity, vol. 71(8), pp. 4516-4525.
Akita, EM et al, J. Immunol. Methods, Apr. 2, 1993, vol. 160(2), pp. 207-214 (Abstract Only).
Fairbrother, JM et al, Distribution of a novel locus call Paa (porcine attaching and effacing associted) among entericEscherichia coli. Advances on Experimental Medicine and Biology, vol. 473, pp. 179-184, 1999 (Abstract Only).
An H et al. “Distribution of a novel locus called paa (porcineattaching and effacingassociated) among entericEscherichia coli” Advances in Experimental Medicine and Biology 2000 US 473:179-184.
Li Y et al. “Human response toEscherichia coli0157:H7 Infection : antibodies to secreted virulence factors.” Infection and Immunity, American Society for Microbiology, Sep. 2000, 68 :5090-5095.
Marquardt R R et al. “Passive protective effect of egg-yolk antibodies against enterotoxigenicEscherichia colik88+infection in neonatal and early-weaned piglets”. FEMS Immunology and Medical Microb. Apr. 1999, 23:283-288.
Nataro James P et al. “DiarrheagenicEscherichia coli”. Clinical Microbiology Reviews. Jan. 1998, 11:142-201.
Capiroli et al. “EnterohaemorrhagicEscherichia coli: emerging issues on virulence and modes of transmission”,Vet. Res.36:289-311 (2005).
Nataro et al. “DiarrheagenicEscherichia coli”Clinical Microbiology Reviews11(1):142-201 (1998).
Robinson et al. “Shiga toxin of enterohemorrhagicEscherichia colitype 0157:H7 promotes intestinal colonization”PNAS103(25):9667-9672 (2006).
Son et al. “Immunological Characterization ofEsherichia coli0157:H7 Intimin γ1”Clinical and Diagnostic Laboratory Immunology9(1):46-53 (2002).
Batisson Isabelle
Fairbrother John M.
Girard Francis
Guimond Marie-Pierre
Harel Josée
Myers Bigel Sibley & Sajovec P.A.
Navarro Mark
Portner Ginny
Valorisation-Recherche, Societe en Commandite
LandOfFree
Antibodies for preventing and treating attaching and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies for preventing and treating attaching and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies for preventing and treating attaching and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4027240